The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Myocarditis is an inflammatory condition of the heart muscle, while pericarditis entails inflammation ... eventually experience “resolution of symptoms,” according to the Centers for Disease ...

Senior Biden Food and Drug Administration (FDA) officials spent weeks casting doubt on reports of cardiac risks associated with the ...

A major revision to the schedule for COVID-19 vaccines comes on the heels of Sen. Ron Johnson’s, R-Wis., issuance of an ...

Pericarditis refers to inflammation ... who were diagnosed with COVID-19 vaccine-associated myocarditis, 89 reported cardiac symptoms after about 91 days. Forshee said one of the study’s ...

As much of the world moves on from the early chaos of the pandemic, a new COVID-19 variant is quietly making its way through ...

For those who experienced symptoms like heart inflammation ... to the Pfizer and Moderna labels about the risk of myocarditis and pericarditis. But by then, millions of people — including ...

The FDA is requiring Novavax to conduct postmarketing studies examining the risk of myocarditis and pericarditis—heart ... recipients experienced 1.7 symptoms on average versus 2.8 symptoms ...

Detailed price information for Cardiol Therapeutics Inc (CRDL-T) from The Globe and Mail including charting and trades.